Products

The compound (2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine 4-methylbenzenesulfonate, also known as the sulfonate ester of (2R,3S)-1-[[3,5-bis(trifluoromethyl)phenyl]oxy]-3-(4-fluorophenyl)morpholine, possesses interesting properties that make it suitable for various applications in the fields of pharmaceuticals and organic synthesis.One potential use of this compound lies in its pharmacological activity. The presence of the fluorophenyl and morpholine groups, combined with the stereochemistry of the molecule, contributes to its potential as a pharmacophore. The compound's ability to interact with specific receptor sites or enzymes in the body could lead to the development of novel drugs targeting various therapeutic areas. The trifluoromethylphenyl moiety has been recognized as a privileged structure due to its diverse biological activities, including antiviral, anticancer, and anti-inflammatory properties. Thus, the compound could be explored as a lead compound or pharmacophoric fragment in drug discovery programs.Additionally, the sulfonate ester moiety in this compound is often used as a protecting group in organic synthesis. It can be selectively introduced and later removed under controlled conditions, allowing for the protection of sensitive functional groups during complex chemical reactions. This protecting group strategy is particularly valuable in the synthesis of complex molecules, such as pharmaceutical intermediates, where the presence of multiple reactive functional groups may lead to undesirable side reactions. The use of this compound as a protecting group can enhance both the yield and selectivity of the desired products.Furthermore, the compound's stereocenter and unique structure could be utilized as a chiral building block in the synthesis of enantiopure compounds. The chiral nature of the compound could be harnessed to create molecules with specific three-dimensional arrangements, leading to the development of potential drug candidates or other bioactive compounds.In summary, the compound (2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine 4-methylbenzenesulfonate holds promise for various applications in pharmaceuticals and organic synthesis. Its potential pharmacological activity, along with its protecting group functionality and chiral character, makes it a valuable tool in drug discovery and organic chemistry research. Continued